NYSE$COR

Cencora Inc · Q3 2023 earnings

Q3 2023 earnings · · Investor relations

Briefing

Revenue increased by 11.5% year-over-year, with GAAP diluted EPS at $2.35 and adjusted diluted EPS at $2.92. Adjusted diluted EPS guidance was raised to $11.85 to $11.95 for fiscal year 2023.

Cencora reported a strong Q3 2023 with revenue reaching $66.9 billion, an 11.5% increase year-over-year. GAAP diluted EPS was $2.35, and adjusted diluted EPS was $2.92. The company raised its adjusted diluted EPS guidance for fiscal year 2023 to a range of $11.85 to $11.95.

  • Revenue increased 11.5% year-over-year to $66.9 billion.
  • GAAP diluted EPS was $2.35, compared to $1.92 in the prior year.
  • Adjusted diluted EPS increased 11.5% to $2.92 from $2.62 in the prior year.
  • Adjusted diluted EPS guidance raised to $11.85 to $11.95 for fiscal year 2023.

Headline financials

Total Revenue

$66.9B

Previous: $60.1B+11.5%
EPS (adj)

$2.92

Previous: $2.62+11.5%
Effective Tax Rate

21.3%

Previous: 23.7%-10.1%
Capital Expenditures

-$283M

Previous: -$323M+12.4%
Free Cash Flow

$197M

Previous: $84.2M+133.5%
Net Income

$480M

Previous: $407M+17.8%
Operating Income

$670M

Previous: $487M+37.5%
Gross Profit

$2.26B

Previous: $2.02B+12.4%
Cash & Equivalents

$1.39B

Previous: $3.03B-54.2%
Total Assets

$61.2B

Previous: $57.2B+7.0%
Stock-Based Comp

$20.6M

Previous: $14.4M+42.9%

Revenue & EPS history

Cencora · Revenue · Quarterly

$66.9B

Q3 2023+11.5%vs Q3 2022
Beat estimate in 8 of 15 quarters(53%)
ActualEstimate

Forward guidance

AmerisourceBergen is updating its fiscal year 2023 financial guidance to primarily reflect its strong performance to date and updated foreign currency translation rates.

Tailwinds

  • Revenue growth to be at least 8 percent, up from the previous range of 6 to 8 percent.
  • U.S. Healthcare Solutions revenue growth to be at least 9 percent, up from the previous range of 7 to 8 percent.
  • International Healthcare Solutions revenue growth to be in the range of 1 to 4 percent, up from the previous range of a 3 percent decline to flat.
  • Adjusted Diluted Earnings Per Share to be in the range of $11.85 to $11.95, representing growth of 7 to 8 percent, raised from the previous range of $11.70 to $11.90.
  • Adjusted free cash flow to be at least $2 billion, from the previous guidance of approximately $2 billion.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2023

Historical avgQ3 2023

-0.1%

Avg return

Earnings day

+0.3%

Avg return

5 days after

+1.4%

Avg return

30 days after

48%

35 / 73 earnings

Positive

+7.8%

Q2 2019

Best reaction

-18.4%

Q2 2026

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2026-18.4%-16.6%-10.1%
Q1 2026-5.9%+0.4%-0.9%
Q4 2025+2.9%+5.8%-1.4%
Q3 2025-2.9%-0.6%+0.1%
Q2 2025+4.6%-4.3%-0.6%
Q1 2025+0.7%-2.1%+1.2%
Q4 2024+5.9%+6.5%+4.0%
Q3 2024+5.8%+4.4%+3.7%
Q2 2024-6.0%-6.3%-5.2%
Q1 2024+7.4%+6.2%+7.5%
Q4 2023+4.2%+4.7%+9.0%
Q3 2023+1.2%-1.3%-7.5%
Q2 2023+0.1%+0.7%+3.5%
Q1 2023-6.2%-8.6%-7.6%
Q4 2022+4.4%+3.1%+12.4%
Q3 2022-2.5%-1.5%+3.4%
Q2 2022+2.9%+4.4%-2.5%
Q1 2022+0.2%+1.3%+7.0%
Q4 2021-0.6%-2.8%-9.0%
Q3 2021-1.5%-2.8%+1.2%
Q2 2021-6.5%-2.1%-7.1%
Q1 2021+3.9%+1.8%-0.7%
Q4 2020-1.0%+4.8%-1.9%
Q3 2020-3.0%-1.6%-7.7%
Q2 2020+3.0%+3.6%+15.8%
Q1 2020-4.8%-2.0%-6.2%
Q4 2019+1.6%+1.0%+4.2%
Q3 2019+3.8%-3.5%-5.6%
Q2 2019+7.8%+5.5%+6.1%
Q1 2019+6.7%+9.2%+5.7%
Q4 2018-2.3%+0.3%-2.9%
Q3 2018+1.9%+5.0%+13.2%
Q2 2018-4.3%-5.1%-6.6%
Q1 2018+2.5%-2.9%+4.7%
Q4 2017-2.4%-2.2%+10.9%
Q3 2017-11.4%-12.0%-12.1%
Q2 2017+3.9%+5.9%+13.2%
Q1 2017+6.0%+6.8%+9.9%
Q4 2016+3.6%+3.1%+12.9%
Q3 2016+5.1%+4.5%+1.9%
Q2 2016-9.2%
Q1 2016-3.7%
Q4 2015-1.0%
Q3 2015-5.4%
Q2 2015+1.9%
Q1 2015+0.4%
Q4 2014+7.1%
Q3 2014+3.7%
Q2 2014-3.1%
Q1 2014-4.3%
Q4 2013+1.8%
Q3 2013-0.0%
Q2 2013-4.6%
Q1 2013-5.1%
Q4 2012-0.6%
Q3 2012+2.7%
Q2 2012-1.2%
Q1 2012+2.4%
Q4 2011-1.0%
Q3 2011-0.5%
Q2 2011+2.9%
Q1 2011+0.5%
Q4 2010-0.5%
Q3 2010-0.7%
Q2 2010+1.0%
Q1 2009-1.7%
Q1 2010+1.2%
Q4 2009-0.6%
Q2 2009-0.6%
Q4 2007-0.6%
Q3 2008-0.5%
Q3 2009-0.5%
Q4 2008-0.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro